Shanghai Rightongene Biotechnology Balance Sheet Health
Financial Health criteria checks 4/6
Shanghai Rightongene Biotechnology has a total shareholder equity of CN¥951.3M and total debt of CN¥16.3M, which brings its debt-to-equity ratio to 1.7%. Its total assets and total liabilities are CN¥1.0B and CN¥75.2M respectively.
Key information
1.7%
Debt to equity ratio
CN¥16.25m
Debt
Interest coverage ratio | n/a |
Cash | CN¥227.49m |
Equity | CN¥951.32m |
Total liabilities | CN¥75.25m |
Total assets | CN¥1.03b |
Recent financial health updates
No updates
Financial Position Analysis
Short Term Liabilities: 688217's short term assets (CN¥497.6M) exceed its short term liabilities (CN¥41.9M).
Long Term Liabilities: 688217's short term assets (CN¥497.6M) exceed its long term liabilities (CN¥33.3M).
Debt to Equity History and Analysis
Debt Level: 688217 has more cash than its total debt.
Reducing Debt: 688217's debt to equity ratio has increased from 0.9% to 1.7% over the past 5 years.
Debt Coverage: 688217's debt is well covered by operating cash flow (123.1%).
Interest Coverage: Insufficient data to determine if 688217's interest payments on its debt are well covered by EBIT.